Tomoya Hinohara, MD
Interventional Cardiology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 11
- Since medical school
- 12 years
- Oregon Health Sciences University School of Medicine, 2014
Offices
11 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hinohara’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Texas T8557Physician License · since 2022 · expires 2025-08-31Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$139,558
Medicare paid this office $139,558 for 859 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of leg arteries or artery grafts | 113 | $19,296 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $13,823 | $206 |
| Return visit (30+ min) | 97 | $12,829 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $9,110 | $138 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 58 | $8,363 | $144 |
See all 25 services
| Ultrasound of leg arteries or artery grafts | 113 | $19,296 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $13,823 | $206 |
| Return visit (30+ min) | 97 | $12,829 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $9,110 | $138 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 58 | $8,363 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,949 | $101 |
| New patient visit (45+ min) | 43 | $6,797 | $158 |
| Ultrasound of both sides of head and neck blood flow | 46 | $5,640 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $5,438 | $247 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $4,862 | $62 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,512 | $196 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $4,109 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 165 | $2,292 | $14 |
| Short return visit (20+ min) | 14 | $1,438 | $90 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 82 | $1,384 | $15 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,159 | $105 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $1,043 | $87 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 41 | $950 | $23 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $864 | $79 |
| Heart rhythm recording of continous external ekg over 8-15 days | 40 | $535 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 20 | $483 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $401 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $367 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $262 | $10 |
| Ultrasound of heart, follow-up | 11 | $257 | $21 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 18 | More than 45% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
859 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 17% · Women 49% · Also on Medicaid 11% · Health risk score 1.64. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 52% · Diabetes 39% · Atrial fibrillation 39% · Heart failure 35% · Chronic kidney disease 33% · COPD 23% · Depression 21% · Cancer 19% · Stroke 16% · Dementia 13%.
The office billed $573,458, Medicare allowed $181,104 and paid $139,558; for 1,465 services of 73 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 859 | 1,465 | 76 | 1.64 | $573,458 | $139,558 |
| 2023 | 955 | 1,678 | 75 | 2.13 | $642,132 | $165,564 |
| 2022 | 327 | 513 | 75 | 2.08 | $150,699 | $35,635 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Ultrasound of leg arteries or artery grafts | 288 | $56,425 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $12,663 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $12,396 | $91 |
| Return visit (30+ min) | 45 | $9,418 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $9,361 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $9,253 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 36 | $7,062 | $191 |
| Ultrasound of both sides of head and neck blood flow | 41 | $6,333 | $154 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,133 | $361 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $4,157 | $148 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $3,266 | $51 |
| Ultrasound scan of abdominal aorta | 16 | $1,739 | $109 |
| New patient visit (45+ min) | 12 | $1,616 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 230 | $1,508 | $6 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,342 | $71 |
| Ultrasound of one leg arteries or artery grafts | 12 | $1,220 | $102 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,102 | $92 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $630 | $10 |
| X-ray of chest, 2 views | 14 | $363 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $359 | $11 |
| Insertion of needle into vein for collection of blood sample | 21 | $218 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 15 | $137 | $8 |
| Blood test, comprehensive group of blood chemicals | 11 | $114 | $10 |
| Magnesium level | 12 | $79 | $7 |
| Blood test, clotting time | 12 | $50 | $4 |
2022: 9 services
| Ultrasound of leg arteries or artery grafts | 32 | $6,459 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,019 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $5,089 | $78 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,363 | $198 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 43 | $2,331 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $2,303 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $1,804 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 163 | $1,217 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $222 | $10 |
Medicaid work
$71 in 2024
Medicaid paid $71 for 14 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | $71 |
| 2024 | 14 | 1 | 14 | $71 |
| 2023 | 165 | 1 | 45 | $652 |
| 2022 | 139 | 1 | 47 | $665 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 165 | $652 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 139 | $665 |
Drugs they prescribed that Part D paid
$129,334
Pharmacies billed $129,334 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 562) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
413 generic and 149 brand-name prescriptions · $129,334 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 53 | $54,966 | $1,037 |
| Entresto | 25 | $17,400 | $696 |
| Xarelto | 11 | $11,638 | $1,058 |
| Farxiga | 12 | $10,357 | $863 |
| Brilinta | 14 | $10,258 | $733 |
See all 18 drugs
| Eliquis | 53 | $54,966 | $1,037 |
| Entresto | 25 | $17,400 | $696 |
| Xarelto | 11 | $11,638 | $1,058 |
| Farxiga | 12 | $10,357 | $863 |
| Brilinta | 14 | $10,258 | $733 |
| Repatha Sureclick | 12 | $9,258 | $771 |
| Nifedipine Er | 27 | $898 | $33 |
| Atorvastatin | 87 | $739 | $8 |
| Metoprolol | 49 | $693 | $14 |
| Clopidogrel | 36 | $674 | $19 |
| Rosuvastatin | 24 | $360 | $15 |
| Ezetimibe | 19 | $293 | $15 |
| Carvedilol | 18 | $278 | $15 |
| Losartan | 19 | $244 | $13 |
| Lisinopril | 20 | $175 | $9 |
| Furosemide | 23 | $156 | $7 |
| Amlodipine Besylate | 13 | $142 | $11 |
| Spironolactone | 15 | $124 | $8 |
Year by year
| 2024 | 562 | 173 | 0% (0) | 27% | $129,334 |
| 2023 | 242 | 58 | 0% (0) | 15% | $38,402 |
| 2022 | 48 | 22 | 0% (0) | None | $5,247 |
| 2021 | 73 | 22 | 0% (0) | 16% | $5,461 |
| 2020 | 191 | 28 | 0% (0) | 19% | $24,756 |
| 2019 | 274 | 57 | 0% (0) | 22% | $41,376 |
| 2018 | 314 | 80 | 0% (0) | 20% | $29,026 |
| 2017 | 100 | 33 | None | None | $14,821 |
| 2016 | 214 | 64 | None | 19% | $17,954 |
| 2015 | 170 | 52 | None | 19% | $12,480 |
| 2014 | 59 | 27 | None | None | $4,006 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Eliquis | 15 | $12,802 | $853 |
| Atorvastatin | 45 | $983 | $22 |
| Nifedipine Er | 16 | $796 | $50 |
| Clopidogrel | 21 | $570 | $27 |
| Furosemide | 23 | $140 | $6 |
2022: 1 drug
| Clopidogrel | 24 | $255 | $11 |
2021: 2 drugs
| Metoprolol | 22 | $429 | $19 |
| Clopidogrel | 13 | $138 | $11 |
2020: 7 drugs
| Entresto | 15 | $12,122 | $808 |
| Xarelto | 16 | $9,895 | $618 |
| Metoprolol | 19 | $532 | $28 |
| Carvedilol | 28 | $246 | $9 |
| Atorvastatin | 19 | $231 | $12 |
| Spironolactone | 14 | $164 | $12 |
| Losartan | 11 | $69 | $6 |
2019: 10 drugs
| Xarelto | 21 | $19,767 | $941 |
| Eliquis | 11 | $5,226 | $475 |
| Metoprolol | 27 | $858 | $32 |
| Atorvastatin | 16 | $419 | $26 |
| Carvedilol | 12 | $169 | $14 |
| Losartan | 17 | $142 | $8 |
| Spironolactone | 13 | $126 | $10 |
| Lisinopril | 16 | $117 | $7 |
| Furosemide | 13 | $58 | $4 |
| Hydrochlorothiazide | 12 | $46 | $4 |
2018: 8 drugs
| Xarelto | 21 | $10,655 | $507 |
| Potassium Chloride | 13 | $3,916 | $301 |
| Metoprolol | 42 | $950 | $23 |
| Atorvastatin | 30 | $525 | $18 |
| Lisinopril | 11 | $92 | $8 |
| Carvedilol | 23 | $81 | $4 |
| Simvastatin | 11 | $74 | $7 |
| Furosemide | 20 | $62 | $3 |
2016: 1 drug
| Amlodipine Besylate | 21 | $137 | $7 |
2015: 1 drug
| Hydrochlorothiazide | 12 | $70 | $6 |
Money from drug and device companies
$3,090 in 2025
| 2025 | 4 | 17 | $2,430 | $3,090 |
| 2024 | 8 | 17 | None | $945 |
| 2023 | 8 | 27 | None | $997 |
| 2022 | 4 | 31 | None | $2,754 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Corevalve Evolut R | $2,679 | 11 payments
|
| Heartflow | Ffrct | $205 | 3 payments
|
| Boston Scientific | Watchman Flx | $136 | 2 payments
|
| Abiomed | None | $71 | 1 payment
|
See all 17 published payments
| Medtronic | Meals · 2025-12-31 | Corevalve Evolut R | $8 |
| Medtronic | Meals · 2025-12-16 | Onyx Frontier | $10 |
| Medtronic | Meals · 2025-12-16 | Onyx Frontier | $2 |
| Medtronic | Meals · 2025-12-16 | Onyx Frontier | $8 |
| Medtronic | Meals · 2025-11-03 | Corevalve Evolut R | $22 |
| Medtronic | Meals · 2025-10-29 | Corevalve Evolut R | $23 |
| Medtronic | Paid to speak or teach · 2025-10-28 | Corevalve Evolut R | $2,430 |
| Medtronic | Meals · 2025-10-28 | Corevalve Evolut R | $133 |
| Medtronic | Meals · 2025-10-28 | Corevalve Evolut R | $29 |
| Heartflow | Meals · 2025-10-20 | Ffrct | $115 |
| Heartflow | Meals · 2025-10-14 | Ffrct | $58 |
| Abiomed | Meals · 2025-10-01 | None | $71 |
| Medtronic | Meals · 2025-08-11 | Corevalve Evolut R | $9 |
| Medtronic | Meals · 2025-08-05 | Corevalve Evolut R | $6 |
| Heartflow | Meals · 2025-05-19 | Ffrct | $32 |
| Boston Scientific | Meals · 2025-03-20 | Watchman Flx | $84 |
| Boston Scientific | Meals · 2025-03-06 | Watchman Flx | $52 |
See earlier years (2024, 2023, 2022)
2024: $945
| Medtronic | Corevalve Evolut R | $296 | 3 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $291 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $136 | 4 payments
|
| Philips North America | (Bq9) Coronary Ivus | $113 | 1 payment
|
| Boston Scientific | None | $40 | 2 payments
|
| Cardiva Medical | Other | $35 | 1 payment
|
| CVRx | Barostim Neo System | $26 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $7 | 1 payment
|
2023: $997
| Medtronic | Corevalve Evolut R | $651 | 15 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $123 | 4 payments
|
| Canon Medical Systems USA | Pet-Ct Scanner | $99 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $36 | 1 payment
|
| Biosense Webster | Carto 3 | $34 | 1 payment
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $30 | 1 payment
|
| Amgen | Repatha | $13 | 1 payment
|
| Cardiovascular Systems | None | $12 | 1 payment
|
2022: $2,754
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $2,055 | 20 payments
|
| Medtronic | Corevalve Evolut R | $369 | 9 payments
|
| Abbott Laboratories | Mitraclip | $237 | 1 payment
|
| Teleflex | Turnpike | $93 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1659799799
- Licence
- TX T8557Texas T8557: Canc Non-Renewal
- Trained
- Oregon Health Sciences University School of Medicine, 2014 · 12 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-04-05
- NPI last updated
- 2024-08-16
- NPI record certified
- 2024-08-16
This is when the NPI record was last certified, not a medical board exam.